Optonol (acquired by Alcon/Novartis) developed Ex-PressTM, a microscopic glaucoma shunt that is transforming glaucoma therapy globally on its way to becoming the gold standard in glaucoma surgery.
Investors 1
| Date | Name | Website |
| - | Israel Hea... | ihcv.co.il... |